News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,061 Results
Type
Article (60945)
Company Profile (441)
Press Release (642675)
Section
Business (194811)
Career Advice (3459)
Deals (35288)
Drug Delivery (102)
Drug Development (84538)
Employer Resources (176)
FDA (17145)
Job Trends (15415)
News (341825)
Policy (34692)
Tag
Academia (2901)
Africa (1013)
Alliances (50983)
Alzheimer's disease (1225)
Approvals (17082)
Arizona (142)
Artificial intelligence (74)
Asia (42149)
Australia (7224)
Bankruptcy (344)
Best Places to Work (11780)
Biosimilars (65)
Biotechnology (329)
C2C Services and Suppliers (75327)
California (1586)
Canada (828)
Cancer (364)
Career advice (2924)
Cell therapy (118)
China (114)
Clinical research (65655)
Collaboration (117)
Colorado (69)
Connecticut (64)
COVID-19 (2658)
Cystic fibrosis (75)
Data (126)
Diabetes (71)
Diagnostics (6092)
Drug pricing (76)
Earnings (72286)
Employer resources (149)
Europe (95644)
Events (110019)
Executive appointments (93)
FDA (17311)
Florida (210)
Funding (99)
Gene therapy (88)
GLP-1 (581)
Government (4741)
Healthcare (19794)
Hotbed/Location (467524)
Idaho (60)
Illinois (271)
Indiana (139)
Infectious disease (2683)
Inflammatory bowel disease (97)
Interviews (679)
IPO (16193)
Job creations (3742)
Job search strategy (2401)
Kansas (93)
Layoffs (419)
Legal (7892)
Liver cancer (60)
Lung cancer (81)
Manufacturing (84)
Maryland (347)
Massachusetts (1405)
Medical device (13245)
Medtech (13247)
Mergers & acquisitions (18907)
Metabolic disorders (250)
Michigan (116)
Minnesota (202)
Neuroscience (1346)
New Jersey (484)
New York (495)
NextGen Class of 2024 (7132)
Non-profit (4853)
North Carolina (636)
Northern California (701)
Obesity (155)
Ohio (99)
Opinion (228)
Pennsylvania (516)
People (55579)
Pharmaceutical (86)
Phase I (20322)
Phase II (28822)
Phase III (21691)
Pipeline (92)
Postmarket research (2774)
Preclinical (8845)
Press Release (69)
Rare diseases (122)
Real estate (5969)
Recruiting (70)
Regulatory (23000)
Research institute (2569)
Resumes & cover letters (560)
South America (1341)
Southern California (634)
Startups (3704)
Texas (184)
United States (7653)
Vaccines (517)
Washington State (248)
Weight loss (145)
Date
Last 7 days (478)
Last 30 days (2253)
Last 365 days (39121)
2024 (25613)
2023 (41472)
2022 (52684)
2021 (57299)
2020 (55914)
2019 (49205)
2018 (37327)
2017 (34534)
2016 (34400)
2015 (39512)
2014 (32436)
2013 (27960)
2012 (29566)
2011 (29960)
2010 (28316)
704,061 Results for "the alliance for regenerative medicine arm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector
Veristat, the Science-First Full Service CRO and Consultancy, announced it has joined the Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of cell and gene therapies for patients, healthcare systems, and society.
April 3, 2024
·
3 min read
Business
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. and Minaris Regenerative Medicine Co., today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
June 20, 2024
·
6 min read
BioForest
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001
Aurion Biotech today announced that the U.S. Food and Drug Administration (FDA) has granted both Breakthrough Therapy Designation (BTD) and Regenerative Medicine Advanced Therapy (RMAT) Designation for AURN001, the Company’s allogeneic cell therapy candidate for the treatment of corneal edema secondary to corneal endothelial disease.
June 19, 2024
·
4 min read
XNK Therapeutics to present at Redeye Regenerative Medicine/Cell Therapy event
XNK Therapeutics AB announced that Johan Liwing, CEO, will present the company at the Redeye Regenerative Medicine/Cell Therapy event on February 14.
February 8, 2024
·
1 min read
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
Senti Biosciences, Inc., a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, announced that the California Institute for Regenerative Medicines has awarded an $8 million grant to Senti Bio.
July 1, 2024
·
9 min read
Press Releases
Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)
Humacyte, Inc. has been granted the U.S. Food and Drug Administration’s (FDA’s) Regenerative Medicine Advanced Therapy (RMAT) designation for patients with advanced peripheral artery disease (PAD).
July 1, 2024
·
6 min read
BioMidwest
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC)
Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine Accelerating Medicines Partnership Bespoke Gene Therapy Consortium.
May 23, 2024
·
3 min read
Biotech Beach
CytoHub Bolsters Team with Top Industry Experts to Enhance Leadership in Cell Therapy and Regenerative Medicine Innovation
CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, announced the strategic addition of three top industry experts to its team.
May 6, 2024
·
2 min read
Policy
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
TScan Therapeutics, Inc. announced that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation to TSC-100 and TSC-101, the Company’s two lead TCR-T therapy candidates for the treatment of heme malignancies.
May 29, 2024
·
7 min read
Policy
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
uniQure N.V. announced that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation for its investigational gene therapy AMT-130 for the treatment of Huntington’s disease.
June 3, 2024
·
8 min read
1 of 70,407
Next